The yeast killer phenomenon: a hypothetical way to control Pneumocystis carinii pneumonia.
Pneumocystis carinii is an important agent of pneumonia in immunocompromised individuals, especially in acquired immunodeficiency syndrome AIDS patients P. carinii attaches specifically to type 1 pneumocytes. Although this phenomenon must play a marked role in pneumocystosis pathophysiology, no therapeutic molecules able to inhibit specifically the parasite attachment were found. A killer toxin, secreted by the yeast Pichia anomala, induced a significant decrease in P. carinii in vitro attachment and inhibited the parasite infectivity in SCID mice. Killer toxins cannot be used as systemic antibiotics. However, it was possible to produce antiidiotypic antibodies against a monoclonal antibody specific of the toxin active site. These antilds were shown to mimic the in vitro killer effect for the toxin and were called 'antibiobodies'. The susceptibility of P. carinii to the antimicrobial activity of the killer toxin made it possible to hypothesize that the killer phenomenon could constitute a new way for the treatment and prophylaxis of P. carinii infections.
Cailliez
J C
JC
Unite 42 INSERM, Villeneuve d'Ascq, France.
Séguy
N
N
Aliouat
E M
EM
Polonelli
L
L
Camus
D
D
Dei-Cas
E
E
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000494:pharmacology; D006801:Humans; D009183:Mycotoxins / Q000276:immunology / Q000494:pharmacology; D010843:Pichia / Q000737:chemistry; D011010:Pneumocystis; D011020:Pneumonia, Pneumocystis / Q000517:prevention & control*
D000888:Antibodies, Anti-Idiotypic; D009183:Mycotoxins